Abbott Japan Launches AccuGen HIV-1 Testing Agent
This article was originally published in PharmAsia News
Executive Summary
Tokyo based Abbott Japan launched real-time polymerase chain reaction testing agent AccuGen m-HIV-1. Designed to be use with Abbott's m2000 rt analyzer, the testing agent is the first HIV RNA testing agent using real-time PCR. The product is able to test a wide range of virus loads. Abbott obtained manufacturing and marketing approval last November and received a NHI price listing last December. (Click here for more - Japanese language
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.